Prophase
- Company typePrivate
- Founded-
- HeadquartersWarszawa, Poland
- Headcount1–10
- GTM typeB2B
- OfferingServices
Prophase firmographics
Firmographics- Name
- Prophase
- Legal name
- PROPHASE Sp. z o. o.
- Website
- https://prophase.eu
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Prophase industry classification
Industry- Product category
- Clinical Trial Support Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
- akta.pro secondary industries
- Site Identification & Feasibility (HLAGACAB), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Clinical CROs (Phase I–IV) (HLAGAAAA)
Keywords
Where Prophase is headquartered
LocationHeadquarters
- HQ city
- Warszawa
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
Prophase business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Others
Revenue model
- Clinical Trial Support Services: Prophase generates revenue through professional services supporting clinical trials conducted by CROs and pharmaceutical companies in Poland. Revenue streams include feasibility analysis, regulatory advisory, monitoring services, employee recruitment/leasing, patient travel expense reimbursement management, and clinical trial documentation archiving. These are primarily project-based or retainer services.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Prophase product offering
Product offeringCore offering
Prophase provides professional clinical trial support services to Contract Research Organizations (CROs) and pharmaceutical companies conducting trials in Poland. Its service portfolio covers feasibility analysis and site/investigator selection, regulatory and contract advisory, monitoring of Phase I-IV trials, employee recruitment and leasing, patient travel expense reimbursement management, and long-term archiving and storage of clinical trial documentation in compliance with Polish law.
Product overview
PROPHASE is an independent Polish company providing clinical trial support services to CROs (Contract Research Organizations) and pharmaceutical companies in Poland. The company offers a unified suite of six integrated services covering the clinical trial lifecycle: Clinical Trials Feasibility Analysis for study planning and site selection; Regulatory and Contract Advisory for regulatory compliance and contract negotiation; Monitoring of Clinical Trials (Phase I-IV) for ongoing trial management; Employee Recruitment and Leasing Support for staffing; Patient Travel Expenses Reimbursement management; and Archiving and Storage of Clinical Trial Documentation for post-trial compliance. These services are delivered as a cohesive offering focused on quality processes and Good Clinical Practice principles.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trials Feasibility Analysis
- Regulatory and Contract Advisory
- Monitoring of Clinical Trials
- Employee Recruitment and Leasing Support
- Patient Travel Expenses Reimbursement
- Archiving and Storage of Clinical Trial Documentation
Companies that use Prophase
Customer profileSegments3 records
Ideal customer profiles3 records
Prophase technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Prophase partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Prophase competitors and assessment
Company assessmentDirect peers
- PSI CRO: Global full-service CRO with European operational hubs including Poland, delivering feasibility, monitoring, regulatory, and project management comparable to Prophase's service lines.
- KCR: Poland-headquartered CRO offering clinical operations, feasibility, site identification, and regulatory services across CEE. Closest comparable to Prophase given shared Polish origin and overlapping scope of clinical trial support services.
- CROMSOURCE: European mid-sized CRO with established Polish operations providing clinical monitoring, feasibility, site management, and regulatory support. Directly comparable service mix and target sponsor base to Prophase.
- Ergomed (now part of Ascertain): CRO with strong Central and Eastern European footprint providing clinical trial management, monitoring, and regulatory services. Comparable as a regional clinical services specialist serving pharma and CRO clients.
Broad incumbents
- Parexel International: Global CRO with established Central European operations offering full clinical development services. Comparable to Prophase in service category but far broader in scope and geography.
- Syneos Health: Biopharmaceutical services organization with global clinical operations including Poland, covering monitoring, feasibility, and regulatory services that overlap with Prophase's offering.
- ICON plc: Global CRO providing clinical trial services including feasibility, monitoring, and regulatory across Poland. Larger incumbent offering overlapping services to pharma and biotech sponsors.
- IQVIA: Largest global CRO with deep Polish country operations covering feasibility, monitoring, regulatory, and site services. Overlaps Prophase's offerings but as part of a vastly broader portfolio.
- Charles River Laboratories: Global CRO providing clinical support services including site identification, monitoring, and regulatory strategy. Overlaps Prophase's services as part of a much broader discovery-to-clinical portfolio.
Emerging players
- Worldwide Clinical Trials: Mid-sized global CRO focused on complex clinical trials across multiple therapeutic areas with European operations. Comparable in offering clinical monitoring and trial support services to sponsors.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks1 record
Key highlights1 record
Customer concentration
Prophase social profiles
Digital presenceProphase financial estimates
Financial estimateRevenue estimate
Valuation estimate
Prophase leadership team
Management profileNumber of profiles
Prophase funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Prophase M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Prophase
What does Prophase do?
Prophase provides professional clinical trial support services to Contract Research Organizations (CROs) and pharmaceutical companies conducting trials in Poland. Its service portfolio covers feasibility analysis and site/investigator selection, regulatory and contract advisory, monitoring of Phase I-IV trials, employee recruitment and leasing, patient travel expense reimbursement management, and long-term archiving and storage of clinical trial documentation in compliance with Polish law.
Is Prophase a public or private company?
Prophase is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Prophase founded?
Prophase was founded in -1. It employs 1 to 10 people.
Where is Prophase based?
Prophase is headquartered in Warszawa, Poland, in the Europe region.
How does Prophase make money?
One revenue line is on record: clinical Trial Support Services.
Who are Prophase's main competitors?
Direct peers on record are PSI CRO, KCR, CROMSOURCE and Ergomed (now part of Ascertain). Broad incumbents are Parexel International, Syneos Health, ICON plc, IQVIA and Charles River Laboratories. Worldwide Clinical Trials is listed as an emerging player.
Does Prophase have an API?
No public API is recorded for Prophase.
What industry is Prophase in?
Prophase's product category is Clinical Trial Support Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGACAB, Site Identification & Feasibility. Its NAICS code is 5417 and its SIC code is 8731.